iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · IEX Real-Time Price · USD
2.150
+0.040 (1.90%)
At close: Jul 19, 2024, 4:00 PM
2.010
-0.140 (-6.51%)
Pre-market: Jul 22, 2024, 5:59 AM EDT

iBio, Inc. Revenue

iBio, Inc. had revenue of $50.00K in the twelve months ending March 31, 2024.

Revenue (ttm)
$50.00K
Revenue Growth
n/a
P/S Ratio
370.82
Revenue / Employee
$1,923
Employees
26
Market Cap
18.54M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20230--
Jun 30, 20221.88M-487.00K-20.54%
Jun 30, 20212.37M733.00K44.75%
Jun 30, 20201.64M-380.00K-18.83%
Jun 30, 20192.02M1.57M354.50%
Jun 30, 2018444.00K50.00K12.69%
Jun 30, 2017394.00K-554.00K-58.44%
Jun 30, 2016948.00K-903.00K-48.78%
Jun 30, 20151.85M1.65M802.93%
Jun 30, 2014205.00K-802.00K-79.64%
Jun 30, 20131.01M-270.00K-21.14%
Jun 30, 20121.28M756.92K145.54%
Jun 30, 2011520.08K--
Jun 30, 20100--
Jun 30, 20091.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aytu BioPharma 93.76M
Biotricity 12.06M
VBI Vaccines 9.41M
Aspira Women's Health 8.99M
Synlogic 3.21M
Aeterna Zentaris 2.37M
Lyra Therapeutics 1.68M
Revenue Rankings